摘要:
A system and method for exchanging telecommunication service information between a telecommunication service provider and a telecommunication service customer include electronically receiving a request in a predefined format to establish an interactive session with a telecommunications customer, determining whether the telecommunications customer is authorized for electronically exchanging information and continuing only if the customer is authorized, parsing the request to identify information related to at least one telecommunications service offered by the telecommunications services provider, the telecommunications service having an associated identification code, determining whether the requested telecommunication service is available in a particular location, and automatically generating information associated with the requested telecommunications service and transmitting the information using the predetermined format to the customer. In one embodiment, the predetermined format is determined by a standards organization, such as ANSI, and transmitted during an interactive session using a TCP/IP connection.
摘要:
This invention pertains to the novel use of anti-rheumatoid arthritic drugs in the treatment of dementia. A method of treating dementia in human beings which comprises administering to the human being a therapeutic amount of a non-steroidal anti-inflammatory drug (NSAID) which has the ability to inhibit prostaglandin synthesis in the human being.
摘要:
The present invention describes to a new and improved handgun holster that provides concealment of and easy access to the firearm when worn on the torso. The device may be worn at different levels along the torso including that of: deep concealment, inside the waistband, and at the midsection of the torso. The holster includes a protective back that acts to guide the user to proper hand placement when drawing the firearm, as the back plate transforms into a cone shape when the user's thumb is pressed against the protective plate of the holster to remove the firearm and the user's fingers are correctly placed along the opposing side of the weapon grip during the drawing act. The handgun holster further acts as a storage compartment by folding the back plate over the grip of a firearm and wrapping and securing the attachment arms around the holster.
摘要:
The present invention describes to a new and improved handgun holster that provides concealment of and easy access to the firearm when worn on the torso. The device may be worn at different levels along the torso including that of: deep concealment, inside the waistband, and at the midsection of the torso. The holster includes a protective back that acts to guide the user to proper hand placement when drawing the firearm, as the back plate transforms into a cone shape when the user's thumb is pressed against the protective plate of the holster to remove the firearm and the user's fingers are correctly placed along the opposing side of the weapon grip during the drawing act. The handgun holster further acts as a storage compartment by folding the back plate over the grip of a firearm and wrapping and securing the attachment arms around the holster.
摘要:
Various embodiments provide methods for the detection, the diagnosis, and/or the progression monitoring of Alzheimer's disease by observing the epigenetic markers in leukocytes. Methods for determining a state of Alzheimer's disease are provided. Accordingly, these methods can comprise the steps of placing a sample comprising at least one blood component onto a substrate labeling the sample to identify at least one epigenetic marker; determining an amount of the at least one epigenetic marker; comparing the amount to a reference value; and determining a state of Alzheimer's disease.
摘要:
A method or technique of detecting, diagnosing, monitoring, and evaluating a neurodegenerative disease, such as Alzheimer's disease, in a human body fluid is disclosed. The invention provides for a method of detecting amyloid peptides associated with erythrocytes and amyloid peptide complement complexes, as a diagnostic test for the detection, monitoring, evaluation or diagnosis of Alzheimer's disease and amyloid-based neurodegenerative diseases. More specifically the invention is directed to a method for detecting presence and amount of amyloid peptides such as amyloid beta (“Aβ”) and Aβ complement complexes, and related complement complexes and compounds with a role in neurodegenerative diseases, in an erythrocyte fraction of a human bodily fluid.